Skip to content

Clinical trials

Terminated Carcinoma, Merkel Cell trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Merkel Cell Status: Terminated Country / region: United States Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20131
20141
20152
20161
20172
20182
20196
20205
20214
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated26

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fate Therapeutics3
Fred Hutchinson Cancer Center3
ImmunityBio, Inc.2
Pfizer2
Ariceum Therapeutics GmbH1
Craig L Slingluff, Jr1
Dana-Farber Cancer Institute1
Exicure, Inc.1
Genocea Biosciences, Inc.1
Incyte Biosciences International Sàrl1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Merkel Cell26
Melanoma14
Carcinoma, Renal Cell11
Small Cell Lung Carcinoma10
Carcinoma, Non-Small-Cell Lung9
Carcinoma, Transitional Cell8
Carcinoma, Hepatocellular7
Stomach Neoplasms7
Uterine Cervical Neoplasms7
Neoplasm Metastasis6

Trials

Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.